Publicaciones en colaboración con investigadores/as de University Health Network (10)

2024

  1. Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis

    Liver International, Vol. 44, Núm. 1, pp. 250-262

2023

  1. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial

    Nature Medicine, Vol. 29, Núm. 6, pp. 1370-1378

2022

  1. Acute kidney injury after cardiac surgery: Sustained low efficiency compared to continuous renal replacement therapy

    Journal of Clinical Anesthesia, Vol. 77

  2. Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 13, Núm. 5, pp. 2373-2382

  3. What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association

    JHEP Reports, Vol. 4, Núm. 12

2021

  1. Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma

    Future Oncology, Vol. 17, Núm. 11, pp. 1295-1310

2019

  1. A phenotypical map of disseminated hepatocellular carcinoma suggests clonal constraints in metastatic sites

    Histopathology, Vol. 74, Núm. 5, pp. 718-730

2018

  1. A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma

    Oncogene, Vol. 37, Núm. 27, pp. 3740-3752

2016

  1. Hepatocellular carcinoma

    Nature Reviews Disease Primers, Vol. 2

2014

  1. Population-based standardized symptom screening: Cancer Care Ontario's edmonton symptom assessment system and performance status initiatives

    Journal of Oncology Practice, Vol. 10, Núm. 3, pp. 212-214